Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
TransMedics Group Stock Quote

TransMedics Group (NASDAQ: TMDX)

$128.77
(1.2%)
$1.55
Price as of May 9, 2024, 4:00 p.m. ET

TransMedics Group Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
TMDX +64.51% +381.74% +36.93% +469%
S&P +25.94% +80.04% +12.48% +78%

TransMedics Group Company Info

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.